drugset / Trial / NCT05256901
Sugammadex vs Neostigmine Reversal in Pediatric Appendectomy
RandomizedParallel-groupSingle-blindOther
Summary
This study is designed as a randomized controlled trial with patients assigned to neuromuscular reversal with either sugammadex or neostigmine/glycopyrrolate reversal. The study will not be blinded to the anesthesiologist to allow for appropriate decision-making on timing and dosage of reversal. This is a single-center study.
Timeline
- Start
- 2023-07-19
- Primary completion
- 2024-07-05
- Completion
- 2024-08-05
Outcome
Outcome not reported
Stopped (Business): “Study was terminated due to lack of funding.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glycopyrrolate | Small molecule | 0.01 mg/kg | — |
| Comparator | Neostigmine | Other / unclassified | 0.07 mg/kg | — |
| Subject | Sugammadex | Other / unclassified | 2 mg/kg | — |
| Subject | Sugammadex | Other / unclassified | 4 mg/kg | — |